Image: ©Jacob Wackerhausen | iStock
UKHSA confirms meningococcal disease cases in Kent, including deaths, with advice on meningitis symptoms, risks, and urgent health response
The UK Health Security Agency (UKHSA) has confirmed multiple cases of invasive meningococcal disease in Kent, which can cause meningitis. The agency is working with local health partners to provide guidance on prevention, early symptom recognition, and urgent care to limit further spread and protect public health.
UKHSA urges antibiotics after Kent meningococcal cases linked to nightclub
The UKHSA has confirmed 4 laboratory cases and 11 notifications remain under investigation, bringing the total to 15. Two people have sadly died from their symptoms.
Investigations reveal that some of the cases visited Club Chemistry in Canterbury between 5 and 7 March before becoming unwell. Health protection teams are working with the nightclub and the University of Kent to limit the spread.
UKHSA is advising all individuals who visited Club Chemistry between the 5th and 7th March to have preventative antibiotic treatment as a precautionary measure. This advice has been extended to the University of Kent’s 16,000 staff and students.
Treatment can be collected from:
Senate Building at the University of Kent,
Gate Clinic, Kent and Canterbury Hospital,
Westgate Hall,
Carey Building at Thanet Hub.
Trish Mannes, UKHSA Regional Deputy Director for the South East, said: “Our thoughts remain with the friends and family involved, and we understand that many people in the university and wider community will be affected by this sad news.
Our investigations have identified that some cases visited Club Chemistry in Canterbury. It is important that anyone who visited the club between 5 and 7 March now comes forward for preventive antibiotic treatment as a precaution, as well as those who were offered antibiotics at the university – these students are being contacted directly through the university.
If you think you may have symptoms of meningitis, do not hesitate to seek medical help by contacting your GP or calling NHS 111.”
Health Secretary speaks out in Parliament
Health Secretary Steve Barclay told Parliament on 17 March 2026 that the meningitis outbreak in Kent is a rapidly developing and “unprecedented” situation, with cases rising and two confirmed deaths. he said most infections are linked to meningococcal group b, a strain many students are not vaccinated against, and confirmed that all cases required hospital treatment.
The government is working with the UK Health Security Agency to trace contacts, provide preventative antibiotics, and limit further spread, particularly among university students. a targeted vaccination programme for those in halls of residence in canterbury will begin, while experts have been asked to review whether wider access to the meningitis b vaccine should be introduced.
He added that the overall risk to the wider public remains low but urged people to be aware of symptoms and seek medical help quickly, stressing that early treatment is critical to saving lives.
What is Meningococcal disease?
Meningococcal disease, which includes meningitis and septicaemia, is a rare but potentially life-threatening illness caused by the meningococcus bacterium. These bacteria can sometimes lead to severe conditions such as inflammation of the brain lining (meningitis) and blood poisoning (septicaemia), both of which can progress rapidly to sepsis if untreated.
The illness often develops suddenly, making early recognition and prompt antibiotic treatment crucial.
Symptoms of meningococcal disease may develop quickly and include:
A rash that does not fade when pressed with a glass
Sudden onset of high fever
Severe or worsening headache
Stiff neck
Vomiting and diarrhoea
Joint and muscle pain
Sensitivity to bright lights
Very cold hands and feet
Seizures
Confusion or delirium
Extreme sleepiness or /difficulty waking.
Young people entering university or college for the first time are particularly at risk because of increased social mixing, which can facilitate the spread of bacteria unknowingly carried in their noses and throats.
There are several strains of meningococcal bacteria. The MenACWY vaccine provides strong protection against MenA, MenC, MenW, and MenY, and is routinely offered to teenagers in Years 9 and 10. However, this vaccine does not protect against all strains; specifically, it does not cover MenB, which can still circulate among young adults.